Long‐Term Mortality and Cardiorenal Outcomes After Metabolic and Bariatric Surgery in Patients With Type 2 Diabetes and Obesity: A Retrospective Cohort Study
- 17 December 2025
- journal article
- Published by Wiley in World Journal of Surgery
- Vol. 50 (1) , 10-20
Abstract
Background: Although prior long‐term studies have demonstrated benefits of metabolic and bariatric surgery (MBS) in patients with type 2 diabetes (T2D) and obesity, we aimed to further substantiate these associations using a large cohort with 10 years of follow‐up. Methods: Surgery and nonsurgery groups were formed, and 1:1 propensity score matching was performed based on baseline characteristics including age, sex, body mass index (BMI ≥ 30 kg/m 2 ), and comorbidities to reduce confounding. The primary endpoint was all‐cause mortality; secondary endpoints included major adverse cardiovascular events (MACEs) and major adverse kidney events (MAKEs) over 10 years. Cox proportional hazards models provided hazard ratios (HRs) with 95% confidence intervals (CIs), and Kaplan–Meier curves illustrated survival. Results: Among 36,666 matched patient pairs ( n = 73,332), all of whom had T2D and obesity, MBS was associated with significantly lower risks of all‐cause mortality (HR 0.67 and 95% CI 0.63–0.71), MACEs (HR 0.67 and 95% CI 0.64–0.70), and MAKEs (HR 0.80 and 95% CI 0.76–0.84). Subgroup and sensitivity analyses confirmed these findings, and E‐values supported the robustness of our findings, suggesting that it would require unmeasured confounders of substantial magnitude to nullify the observed associations. Conclusion: These results suggest durable associations with improved survival and reduced risks of cardiovascular and kidney outcomes, supporting MBS as a potentially effective treatment strategy for patients with type 2 diabetes and obesity. Continued prospective studies are warranted to further validate these associations and inform clinical decision‐making in this high‐risk population.Keywords
This publication has 31 references indexed in Scilit:
- The long‐term effect of bariatric/metabolic surgery versus pharmacologic therapy in type 2 diabetes mellitus patients: A systematic review and meta‐analysisDiabetes/Metabolism Research and Reviews, 2024
- IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045Diabetes Research and Clinical Practice, 2022
- Association of Metabolic Surgery With Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes and ObesityJAMA, 2019
- Laparoscopic sleeve gastrectomy versus Roux-en-Y gastric bypass in cardiovascular risk reduction: A match control studySurgery for Obesity and Related Diseases, 2019
- Bariatric Surgery and Long-term Durability of Weight LossJAMA Surgery, 2016
- Bariatric surgery is associated with improvement in kidney outcomesKidney International, 2016
- The Propensity ScoreJAMA, 2015
- Obesity and Diabetic Kidney DiseaseMedical Clinics of North America, 2013
- Body Mass Index in 1.2 Million Adolescents and Risk for End-Stage Renal DiseaseArchives of internal medicine (1960), 2012
- Laparoscopic sleeve gastrectomy and laparoscopic gastric bypass are equally effective for reduction of cardiovascular risk in severely obese patients at one year of follow-upSurgery for Obesity and Related Diseases, 2011